Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pavmed Inc 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 USA

www.pavmed.com Employees: 107 P: 917-813-1828

Description:

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City.

Key Statistics

Overview:

Market Capitalization, $K 11,069
Enterprise Value, $K -5,581
Shares Outstanding, K 11,069
Annual Sales, $ 2,450 K
Annual Net Income, $ -64,180 K
Last Quarter Sales, $ 1,000 K
Last Quarter Net Income, $ 64,400 K
EBIT, $ -54,620 K
EBITDA, $ -51,690 K
60-Month Beta 0.69
% of Insider Shareholders 14.70%
% of Institutional Shareholders 19.93%
Float, K 9,442
% Float 85.30%
Short Volume Ratio 0.37

Growth:

1-Year Return -68.96%
3-Year Return -98.25%
5-Year Return -92.33%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -19.02%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 11/13/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -3.94
EPS Growth vs. Prev Qtr 35.71%
EPS Growth vs. Prev Year 67.26%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 12/07/23

PAVM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -92.36%
Profit Margin % -2,619.59%
Debt/Equity 0.00
Price/Sales 4.56
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.90
Interest Coverage -133.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar